Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...

The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...

“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...

Switching from aflibercept to ranibizumab biosimilars maintains stability in nAMD treatment, offering a cost-effective ...

Hydrogen production through water electrolysis is a cornerstone of the clean energy transition, but it relies on efficient and stable catalysts that work under acidic conditions—currently dominated by ...

Molecular vanadium cluster on carbon nanotubes switches between oxygen and hydrogen production in acid, depending on assembly, offering a path beyond iridium and platinum. (Nanowerk News) Hydrogen ...

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger ...

Cells fine-tune gene expression in response to cellular stress, a process critical for tumor progression that leads to cancer. However, elucidating mechanisms governing stress-responsive transcription ...

An announcement from 4D Molecular Therapeutics ( (FDMT)) is now available. On November 6, 2025, 4D Molecular Therapeutics announced positive interim results from their Phase 1/2 PRISM clinical trial ...

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes.

4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 million in upfront cash to fund the asset’s phase 3 development. In return for ...